Warner Bros. Discovery, Inc.
Heterocyclic compound as CSF-1R inhibitor and use thereof

Last updated:

Abstract:

The present invention relates to a class of isoindolinone derivatives and use thereof in the preparation of a medicament for treating diseases associated with a novel colony stimulating factor 1 receptor (CSF-1R) inhibitor. In particular, the present invention relates to a compound of formula (I) and a pharmaceutically acceptable salt thereof or a stereoisomer thereof. ##STR00001##

Status:
Grant
Type:

Utility

Filling date:

3 Jan 2019

Issue date:

12 Jul 2022